FDA Inspection
Biomedical Research Foundation of Northwest LouisianaBiomedical Research Foundation of Northwest Louisiana – FDA Inspection, Apr 18, 2024
Record Details
This FDA Inspection record concerns Biomedical Research Foundation of Northwest Louisiana, with an inspection on April 18, 2024, issued by the New Orleans District Office, covering human drugs.
- Inspection Date
- April 18, 2024
- Product Type
- Human Drugs
- People
- Laurie Nelson (Issuing Officer)
- Saundrea A. Munroe (FDA Associated Person)
View Company Profile
ID · cb58d528-7922-4187-94c5-55571acaaa93
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1237238
- FDA center
- Human Drugs
- Project area
- Generic Drug Evaluation
- Outcome
- Form 483 issued
FDA Citations
5- 21 CFR 212.20(d)Determination need for investigation
- 21 CFR 212.30(b)Equipment procedures
- 21 CFR 212.40(a)Suitable for intended use
- 21 CFR 212.50(a)Written control procedures
- 21 CFR 212.70(d)(3)Final dated signature
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Biomedical Research Foundation of Northwest Louisiana
2| Date | Classification | Office | Project area |
|---|---|---|---|
| April 1, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 16, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Biomedical Research Foundation of Northwest Louisiana
- FDA Inspection 979734 - 2016-04-01
- FDA Inspection 831846 - 2013-05-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.